The cannabis market is undergoing an unprecedented global transformation. With the legalization of recreational cannabis in the United States, but now also in Europe and Asia, the expansion of medical cannabis and the structuring of the CBD sector in Europe, the industry is attracting investors, entrepreneurs and major groups to create or finance cannabis businesses.
Canada, Colorado, California... all these states witnessed a veritable green rush for the cannabis industry.
Newsweed deciphers the cannabis business in France and around the world: market trends, company strategies, investments, mergers and acquisitions, regulations, legalization and new trends in the cannabis industry.
Understanding the cannabis economy enables you to anticipate legislative changes, identify investment opportunities and decipher the strategies of the sector's major players.
Eight years after the legalization of cannabis, Quebec’s track record could fuel the French debate on prohibition. According to the latest data from...
The Canadian group Cronos has completed the full acquisition of CanAdelaar, one of the largest licensed cannabis producers in the Netherlands, for a base price of...
British patients can now be prescribed a new variety of medical cannabis rich in tetrahydrocannabivarin (THCV), a cannabinoid that has yet to be fully explored, whose effects...
The Brazilian medical cannabis market continues to grow, driven by an increase in the number of patients, a steady rise in imports, and the gradual evolution of...
Morocco's legal cannabis sector is expanding its international presence, with cannabis resin exports now reaching 15 countries, including France, ...
Canadian cannabis producer Aurora Cannabis has completed a major expansion project at its medical cannabis production facility in Leuna, Germany. Announced...
Tilray Medical has obtained a new license in Portugal, allowing the company to conduct quality tests on medical cannabis directly at its facility...
The battle for Aurora Cannabis is becoming increasingly complex. As Curaleaf attempts a hostile takeover of the Canadian medical cannabis producer, a...
Eight years after cannabis was legalized, the plant has become a major part of Canadian agriculture. According to Statistics Canada figures, cannabis has...
Bedrocan, the pioneer in medical cannabis in Europe, was finally declared bankrupt on Wednesday, October 7, 2026, by a Dutch court, less than two weeks...
The U.S. Drug Enforcement Administration (DEA) continues to integrate medical cannabis into the federal regulatory framework. Since October 5, 2026, producers, distributors, and laboratories...
Curaleaf’s hostile takeover bid for Aurora Cannabis is struggling to break through the barriers. After the board of directors of Aurora Cannabis unanimously rejected its initial proposal...
Bedrocan’s difficulties in the Netherlands could have repercussions beyond the country’s borders. In Denmark, Stenocare is now warning that a disruption in the supply of cannabis products...
Since the launch of recreational sales in late 2022, licensed dispensaries in New York State—which has a population of approximately 20 million—have generated more than...
The European Food Safety Authority (EFSA) issued a favorable opinion in late September regarding the safety of a dietary supplement containing synthetic CBD that was submitted...
Bedrocan, one of the best-known names in the European medical cannabis industry, has been granted a suspension of payments in the Netherlands as financial pressure...
In Canada, a mandatory tax of 0.5% on industrial hemp has gone into effect to fund research and develop domestic markets and...
Yongji Health, a Chinese company that is already a shareholder in Tasmanian Botanics, has completed the acquisition of the shares still held by the Australian producer’s original investors. A transaction worth...
South Korea is preparing to change its approach to medical cannabis. Faced with a rise in the number of patients and the cost of imported treatments,...
Canopy Growth is now selling its medical cannabis flowers in the United Kingdom. The Canadian producer announced on September 22, 2026, that it would supply four strains...